Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Profound Medical Corp., receives CE Mark Approval for TULSA-PRO
TORONTO, April 11, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. ("Profound" or "Company") (TSXV:PRN), a medical device company commercializing a... Read more
Allergan (AGN)'s Rapastinel Snags Breakthrough Tag from the FDA for Depression
DUBLIN, Jan 29, 2016/PRNewswire/ -- Allergan plc. (NYSE: AGN), a leading global pharmaceutical company today announced that its Phase III... Read more